Hill-Rom Holdings, Inc. (HRC) Position Raised by Nordea Investment Management AB

Nordea Investment Management AB lifted its stake in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 13.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 27,134 shares of the medical technology company’s stock after purchasing an additional 3,196 shares during the quarter. Nordea Investment Management AB’s holdings in Hill-Rom were worth $2,008,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Teacher Retirement System of Texas raised its stake in shares of Hill-Rom by 0.3% during the second quarter. Teacher Retirement System of Texas now owns 5,194 shares of the medical technology company’s stock valued at $413,000 after purchasing an additional 14 shares in the last quarter. Stifel Financial Corp raised its stake in shares of Hill-Rom by 0.5% during the second quarter. Stifel Financial Corp now owns 4,379 shares of the medical technology company’s stock valued at $349,000 after purchasing an additional 23 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of Hill-Rom by 0.5% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,734 shares of the medical technology company’s stock valued at $695,000 after purchasing an additional 46 shares in the last quarter. Utah Retirement Systems raised its stake in shares of Hill-Rom by 0.8% during the second quarter. Utah Retirement Systems now owns 12,013 shares of the medical technology company’s stock valued at $956,000 after purchasing an additional 100 shares in the last quarter. Finally, IFP Advisors Inc raised its position in Hill-Rom by 3.0% in the second quarter. IFP Advisors Inc now owns 4,607 shares of the medical technology company’s stock worth $367,000 after acquiring an additional 135 shares in the last quarter. Institutional investors and hedge funds own 82.35% of the company’s stock.

HRC has been the topic of several research reports. KeyCorp reiterated a “buy” rating and issued a $89.00 price target (up from $82.00) on shares of Hill-Rom in a research report on Sunday, November 5th. Stifel Nicolaus reiterated a “buy” rating and issued a $92.00 price target on shares of Hill-Rom in a research report on Wednesday, November 29th. Zacks Investment Research upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $90.00 price target on the stock in a research report on Friday, October 27th. Needham & Company LLC dropped their price target on shares of Hill-Rom from $93.00 to $90.00 and set a “buy” rating on the stock in a research report on Monday, November 6th. Finally, ValuEngine cut shares of Hill-Rom from a “buy” rating to a “hold” rating in a research report on Saturday, November 4th. Five research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Hill-Rom currently has a consensus rating of “Buy” and a consensus target price of $89.57.

In other Hill-Rom news, SVP Andreas G. Frank sold 3,940 shares of Hill-Rom stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total transaction of $306,689.60. Following the transaction, the senior vice president now owns 16,701 shares of the company’s stock, valued at approximately $1,300,005.84. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Andreas G. Frank sold 6,870 shares of Hill-Rom stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $77.48, for a total value of $532,287.60. Following the transaction, the senior vice president now directly owns 16,701 shares in the company, valued at approximately $1,293,993.48. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

Hill-Rom Holdings, Inc. (NYSE:HRC) opened at $83.44 on Friday. The firm has a market capitalization of $5,478.94, a PE ratio of 21.57, a P/E/G ratio of 1.77 and a beta of 1.19. Hill-Rom Holdings, Inc. has a 12 month low of $54.59 and a 12 month high of $85.25. The company has a debt-to-equity ratio of 1.55, a current ratio of 1.77 and a quick ratio of 1.34.

Hill-Rom (NYSE:HRC) last released its earnings results on Friday, November 3rd. The medical technology company reported $1.32 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.27 by $0.05. Hill-Rom had a return on equity of 20.27% and a net margin of 4.87%. The company had revenue of $738.30 million for the quarter, compared to analysts’ expectations of $731.10 million. During the same quarter in the previous year, the business posted $1.18 EPS. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. analysts expect that Hill-Rom Holdings, Inc. will post 4.26 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Shareholders of record on Friday, December 15th will be paid a dividend of $0.18 per share. The ex-dividend date is Thursday, December 14th. This represents a $0.72 annualized dividend and a yield of 0.86%. Hill-Rom’s dividend payout ratio (DPR) is presently 36.18%.

WARNING: This article was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://ledgergazette.com/2017/12/08/hill-rom-holdings-inc-hrc-position-raised-by-nordea-investment-management-ab.html.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply